|Publication number||USRE34239 E|
|Application number||US 07/465,588|
|Publication date||May 4, 1993|
|Filing date||Jan 18, 1990|
|Priority date||Sep 9, 1970|
|Publication number||07465588, 465588, US RE34239 E, US RE34239E, US-E-RE34239, USRE34239 E, USRE34239E|
|Original Assignee||Hospal Ltd.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (14), Non-Patent Citations (25), Referenced by (3), Classifications (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a .Iadd.continuation of application Ser. No. 106,684 filed Oct. 8, 1987, which is an application for reissue of U.S. Pat. No. 4,545,910 issued on application Ser. No. 212,829, filed Dec. 4, 1980, which is .Iaddend.a continuation of application Ser. No. 10,548, filed Feb. 8, 1979, which in turn is a continuation of application Ser. No. 872 911, filed Jan. 27, 1978, which in turn is .Iadd.a .Iaddend.continuation of application Ser. No. 492,217, filed Jul. 26, 1974, which in turn is a continuation-in-part of Ser. No. 178,400 filed Sept. 7, 1971, all now abandoned .Iadd.except for Ser. No. 212,829, which issued as a patent.Iaddend..
The present invention relates to the field of semi-permeable membranes which are particularly suitable for use in fractionation.
Certain membranes have ultra-filtration properties; these are membranes which can, on the one hand, allow small molecules, especially solvent molecules, to pass through them, whilst, on the other hand, retaining larger molecules, the molecular weight limit for distinguishing filtrable units from non-filtrable units being above about 500. The term "ultra-filtration" is used herein to describe a filtration in which the molecular weight limit which distinguishes the filtrable elements from the non-filtrable elements is above about 500.
The term "degree of salt rejection" of a membrane (expressed as a percentage) is defined herein as the number ##EQU1##
The degree of rejection for macromolecules in solution can be defined similarly.
The term "permeability to water" of a membrane under a given relative pressure is used herein to denote the flow of water across a membrane one face of which is in contact with water, the difference in pressure across the membrane being equal to the given relative pressure; the permeability is usually expressed either in liters/day.m2 or in kg/day.m2.
The present invention relates, primarily, to new membranes. According to the present invention, there is provided a semi-permeable membrane which comprises either:
(1) a copolymer of acrylonitrile and at least one ionic or ionisable monomer, or
(ii) a copolymer of acrylonitrile, at least one ionic or ionisable monomer, and at least one non-ionic and non-ionisable monomer, or
(iii) a mixture of at least two copolymers as defined under (i) and/or (ii), or
(iv) a mixture of at least one copolymer as defined under (i) and/or (ii), and at least one copolymer of acrylonitrile and at least one non-ionic and non-ionisable monomer, the ionic or ionisable monomer units representing from 1 to 80 mole % of the monomer units in one of said copolymers, and representing from 1 to 50 mole % of the monomer units, in the membrane, said membrane having a degree of salt rejection (as hereinbefore defined) of less than 1% and a permeability to water (as hereinbefore defined) of more than 100 liters/day.m2 at a relative pressure of 2 bars.
The ionic monomer contact is preferably between 2 and 15 mole % of all the monomers in the membrane. The thickness of the membranes of this invention is generally less than 300 microns, preferably less than 100 microns, but it is usually greater than 0.5 micron.
The ionic or ionisable monomers (hereafter referred to as the "ionic monomers") from which the copolymers are derived are generally olefinically unsaturated monomers containing at least one functional group, such as an optionally salified sulphonic acid or phosphonic acid group, or a quaternary ammonium group. More particularly, they are monomers of formula ##STR1## in which
Y represents a functional group such as those quoted above;
each of R1, R2 and R3, which may be identical or different, represents a hydrogen atom or an alkyl radical of 1 to 4 carbon atoms; preferably, R1 and R2 are both hydrogen atoms and R3 is either a hydrogen atom or a methyl radical;
A represents either
(a) a divalent purely hydrocarbon group the free valencies of which are carried by a purely aliphatic saturated or unsaturated, straight or branched chain, or are carried by an unsubstituted aromatic nucleus or are carried by a mixed monoaromatic-monoaliphatic chain, one of the free valencies being carried by an aliphatic carbon atom and the other free valency being carried by an aromatic carbon atom, or
(b) a divalent chain consisting of aliphatic and/or aromatic hydrocarbon groups bonded to one another by an oxygen or sulphur atom or by a carbonyloxy or 1-oxo-2-aza-ethylene group, the free valencies being carried by aliphatic and/or aromatic carbon atoms, or
(c) a --O--A'-- or --S--A'-- group wherein A' represents a group such as defined above under (a) or (b) for A, or
(d) a divalent group as defined under (a), (b) or (c), in which one or more of the carbon atoms additionally carry substituents, for example hydroxyl groups or halogen atoms, or
(e) a simple valency bond.
The total number of carbon atoms in A is usually less than 12. The acid groups of the ionic comonomers of the acrylonitrile can be in the form of various salts, but are preferably in the form of sodium, potassium or ammonium salts.
Amongst the quaternary ammonium groups which Y can represent, the following may be mentioned: radicals of formulae ##STR2## in which
X.sup.⊖ is an inorganic or organic anion the precise nature of which is not a characteristic of the invention, and which can be replaced by a different anion in accordance with the conventional ion exchange techniques; typical anions include the halides, nitrates, sulphates, sulphites, phosphates and sulphonates;
each of R4, R5 and R6, which may be the same or different, represents a monovalent or polyvalent organic radical, and at least two of these radials can optionally together form a single divalent or trivalent radical, the atoms carrying the free valencies being carbon atoms; if the radicals R4, R5 and R6 are polyvalent, the free radicals may be attached either to one and the same nitrogen atom or to different nitrogen atoms belonging to different macromolecular chains, with one and the same nitrogen atom carrying only single bonds, or at most one intracyclic double bond; preferred monovalent radicals R4, R5 and R6 include optionally substituted alkyl radicals with 1 to 4 carbon atoms, for example methyl, ethyl, propyl, butyl and β-hydroxyethyl radicals; preferred polyvalent radicals include alkylene, alkenylene, alkanetriyl, alkenetriyl, alkylidene and alkenylidene radicals, and homologous radicals containing chain or substituent hetero-atoms such as O, N or S, or possessing alkano or alkeno bridges; amongst these divalent or trivalent radicals, radicals with 4 to 10 carbon atoms are preferably used.
Reference to "copolymer of acrylonitrile and of monomers with quaternary ammonium groups" is not intended to imply anything as regards the process of preparation of the copolymers; in particular it is not intended to imply that these copolymers are actually prepared from acrylonitrile and monomers with quaternary ammonium groups; they can equally well be prepared from acrylonitrile and monomers with tertiary amine groups, with subsequent quaternisation of the non-ionic copolymer obtained.
Suitable ionic monomers from which the copolymers with acrylonitrile may be obtained include
(a) monomers containing sulphonic acid groups: vinylsulphonic, allylsulphonic, methallylsulphonic and styrenesulphonic acids; methylstyrenesulphonic, dimethylstyrenesulphonic and ethylstyrenesulphonic acids; vinylbenzenesulphonic acids, allyloxybenzenesulphonic and methallyloxybenzenesulphonic acids; allyloxy ethylsulphonic and methallyloxyethylsulphonic acids, as well as the salts of these various acids.
(b) monomers with phosphonic groups: vinylphosphonic acid, vinylbenzenephosphonic acid and their salts.
(c) monomers with quaternary ammonium groups; 2-vinyl- and 4-vinyl-N-alkyl-pyridinium salts with an alkyl radical having 1 to 4 carbon atoms; N-allyl- and N-methallyl-pyridinium salts, N-allyl- and N-methallyltrialkylammonium salts, the alkyl radicals containing, in total less than 13 carbon atoms; vinyl-N-alkylpicolinium salts with an alkyl radical having 1 to 4 carbon atoms, especially 5-vinyl-2-methyl-N-alkylpyridinium salt; vinyl-N-alkyllutidinium salts with an alkyl radical having 1 to 4 carbon atoms, especially vinyl-N-alkyl-2,4-dimethylpyridinium salt; o- and p-(vinylphenyl)trialkylammonium salts with the alkyl radicals having a total of less than 13 carbon atoms; vinyl-N-alkylmorpholinium salts with an alkyl radical having 1 to 4 carbon atoms; 2-(trialkylammonium)-ethyl acrylates and methacrylates, the alkyl radicals containing, in total, less than 13 carbon atoms; and acrylamides and methacrylamides homologous to the abovementioned acrylates and methacrylates.
The copolymers of acrylonitrile and of ionic monomers used in the membranes of this invention can, as mentioned above, also contain units derived from other olefinically unsaturated monomers, capable of copolymerising with acrylonitrile; suitable such monomers include ethylenic hydrocarbon monomers such as butadiene and styrene; vinyl and vinylidene chlorides; vinyl ethers; unsaturated ketones such as butenone, phenylvinyl-ketone and methyl-isopropenyl-ketone; vinyl esters of carboxylic acids, for example of formates, acetates, propionates, butyrates and benzoates; alkyl, cycloalkyl and aryl esters of unsaturated monocarboxylic or polycarboxylic aliphatic acids, such as methyl, ethyl, propyl, butyl or β-hydroxyethyl acrylates, methacrylates, maleates, fumarates, citraconates, mesaconates, itaconates and aconitates; acrylamide and methacrylamide and their N-substituted derivatives.
Furthermore, the copolymers of acrylonitrile and an ionic monomer can optionally be crosslinked, for example by divinyl derivatives.
If the membranes according to the invention consist essentially of mixtures of at least two copolymers of acrylonitrile, these mixtures can consist either of several copolymers of acrylonitrile and ionic monomers, or of at least one copolymer of acrylonitrile and an ionic monomer, on the one hand, and at least one copolymer of acrylonitrile and a non-ionic monomer, on the other. In these various types of mixture, the copolymer or copolymers of acrylonitrile and an ionic monomer can contain up to 80 mol % of ionic monomer, the total content of ionic monomer in the mixture however being less than 50 mol %, as indicated above. In these mixtures, the non-ionic monomers which can be used are the same as those which can be used as comonomers with acrylonitrile and the ionic monomers.
The present invention also provides a process for the preparation of semi-permeable membranes, in particular of membranes such as those defined above. This process comprises treating a homogeneous film containing at least one copolymer of acrylonitrile and an ionic monomer, with water or with an aqueous non-solvent mixture at a temperature of between 60° and 250° C., preferably between 80° and 190° C. In the subsequent description, the use of the word "film" will be restricted to liquid or solid films which have not yet undergone the treatment, and the term "membrane" will be restricted to the films of high permeability which have been treated according to the process of this invention.
The homogeneous films containing at least one copolymer of acrylonitrile and an ionic monomer, which can be used as the starting material, have the same chemical composition as the membranes according to the invention. They are well-known products which have a degree of rejection of salt which is not zero and possess a low permeability to water even under high pressure; they can contain residual amounts of solvent but can generally be handled without the aid of a support. They are generally prepared by simple casting of a solution of the copolymer or a solution of a mixture of copolymers on a rigid support and evaporating the solvent. These processes can optionally be followed by crosslinking for example with dihalogenated reagents if the acrylonitrile polymer contains amine groups, or with divinyl compounds.
If a reinforced membrane is required, the starting film should itself be reinforced, and this can easily be achieved by performing the casting operation or a reinforcing support, for example a fabric or net.
The copolymers of acrylonitrile and an ionic monomer used to form the films to be treated with hot water generally have a specific viscosity (measured at 25° C., in a 2 g/l solution in dimethylformamide) of between 0.1 and 3, preferably between 0.5 and 1.5. (These values are for the films before crosslinking if crosslinking is carried out, and before mixing if mixtures are subsequently prepared).
The following documents may be referred to for further details of the preparation of copolymers of acrylonitrile and an ionic or non-ionic monomer, and of films comprising them: British Pat. No. 823,345, French Pat. Nos. 1,446,001 and 1,267,240, U.S. Pat. Nos. 2,601,251, 2,617,781, 2,662,875, 2,691,640, 2,837,500, 2,840,550, 2,883,370 and 2,941,969, Fresenius, Z.Anal. Chem. 238 432-41 (1968) Houben-Weyl, Methoden der Organischen Chemie (Methods of Organic Chemistry), 14/1 p. 998-1009, and Encyclopedia of Polymer Science and Technology 1 374-444 (1964; Interscience Publishers). It is to be appreciated, though, that the preparation is essentially conventional.
The temperature of the water or aqueous mixture used for the treatment in the process of this invention is between 60° and 250° C., preferably between 80° and 190° C. The highest temperatures are generally used to treat films having a low proportion of ionic monomer units; conversely, the lowest temperatures are used to treat films having a high proportion of ionic monomer units. Thus, for films containing less than 5 mol % of units corresponding to a copolymerised ionic monomer, the treatment with water is preferably carried out above 105° C., and below 105° C. where more than 5 mol % of such units is present.
The water or aqueous mixtures used in the process of the invention can be in the vapour phase, but are preferably used in the liquid phase. Of course treatment above 100° C. may require working under pressure if it is desired to use water or a liquid aqueous mixture, but apart from this, the pressure is not a critical factor in the preparation of the membranes of this invention.
The water content in the aqueous mixtures is usually above 50% by weight, preferably above 90%. The water can be mixed with organic solvents or with inorganic or organic electrolytes; preferably, chemically neutral, especially non-basic, mixtures are used, so as not to cause a chemical attack on the acrylonitrile copolymer. A pH of 6 to 8 is generally suitable.
The treatment of the film with water or the aqueous mixture can usually be carried out by simple immersion in an aqueous treatment bath. The process can be carried out continuously or discontinuously and the bath can be either static relative to the film or it can be stirred or circulated. If the process is carried out continuously, it is advantageous to pass the film continuously through the treatment bath. The duration of the treatment should usually be from 5 seconds to 2 hours, but there is no critical upper limit. In practice, no significant change in the properties of the membranes is observed if the treatment is continued for more than 24 hours.
In an advantageous embodiment of the process of this invention after having reached the maximum temperature, the membrane, immersed in its treatment bath, is allowed to return to ambient temperature; this results in membranes having a better performance.
The heat treatment can be simultaneously accompanied by a monoaxial or biaxial stretching. The purpose of this stretching is, generally, to enable one to effect the heat treatment at a lower temperature whilst still obtaining membranes having a good performance; it furthermore makes it possible to obtain an improvement in the mechanical properties; the degree of linear stretching is generally between 20% and 1000%, preferably between 50 and 500%. Of course the heat treatment and the stretching can be carried out in one step or in several stages. Again, better dimensional stability of the stretched membranes can generally be achieved by carrying out a relaxation by leaving the membrane, not under stress, in an aqueous bath at a temperature which is preferably below that of the heat treatment.
Of course, the treatment according to this invention does not affect the symmetry of the film so that the membrane, like the film, is symmetrical and can be used on either side.
The membranes of this invention and especially the membranes prepared as described above, are advantageously stored wet; they can also be stored dry if they are impregnated with hygroscopic plasticiser, for example by temporarily immersing them in glycerine or a water/glycerine mixture.
The present invention also provides an apparatus for the fractionation of liquid mixtures. This apparatus comprises
(α) a first compartment designed to obtain the liquid mixture to be fractionated,
(β) optionally, means of feeding the liquid mixture into the first compartment and means for withdrawing it therefrom (especially in the case of continuous operation),
(γ) a semi-permeable membrane of the present invention forming one of the walls of the first compartment,
(δ) a second compartment, one of the walls of which is the semi-permeable membrane, and which is designed to contain a liquid at least a part of which has passed through the semi-permeable membrane, and
(ε) optionally, means for withdrawing the liquid contained in the second compartment (especially in the case of continuous operation).
The liquid mixtures which can be fractionated are essentially aqueous liquid solutions, suspensions or emulsions; the substances dissolved in these solutions, suspensions or emulsions can be ionic substances such as salts, acids or bases, or non-ionic substances such as low molecular weight solutes, macromolecules and sol- vents.
The term "fractionation" as used herein is intended to cover operations such as concentration, refining and purification.
The membranes of this invention render the apparatus particularly useful in ultra-filtration and in dialysis, because of their low resistance to the passage of low molecular weight material, especially water, and their ability to retain higher molecular weight material. The fractionation apparatuses of this invention divide themselves into two groups, ultra-filtration apparatuses, on the one hand, and dialysis apparatuses, on the other.
In the ultra-filtration apparatus, the permeate (or ultra-filtrate) consists essentially of a solvent (for example water) and, optionally, of other low molecular weight compounds such as ionic solutes, co-solvents, neutral solutes, small organic molecules and oligomers, the molecular weight limit between compounds which can be ultra-filtered and those which cannot be ultra-filtered being generally above 500. Apart from the constituents α to ε mentioned above, the ultra-filtration apparatus of this invention may comprise means which make it possible to establish, in the first compartment, a pressure above that prevailing in the second compartment; this may be provided by having a superatmospheric pressure in the first compartment or a reduced pressure in the second. Other features of the ultra-filtration apparatus include:
A pressure-resistant porous support or a network or grooved support which enables the semi-permeable membrane to withstand pressures better;
means which allows the liquid to be ultra-filtered to be circulated in the first compartment; and
means which provides turbulence or liquid circulation in the first compartment close to the membrane in order to avoid local over-concentration phenomena developing.
In the dialysis apparatus, the migration of the permeate across the membrane takes place under the influence of a difference in concentration between the two compartments; the permeate (or dialysate) essentially consists of low molecular weight compounds (such as salts or ionic solutes, possibly with a little solvent, for example water). Apart from the components α and ε mentioned above, the dialysis apparatus of this invention may comprise means of introducing to the second compartment, a liquid called the dialysis bath.
Other features which may be included in the dialysis apparatus are, for example:
means which allows the liquid to be dialysed to be circulated in the first compartment; and
means which allows the dialysis bath to be circulated in the second compartment.
Of course the preceding discussion relates to over-simplified ultrafiltration and dialysis apparatuses; more complex apparatuses derived therefrom can naturally be used, for example apparatuses consisting of a plurality of unit apparatuses, such as apparatuses of the filter-press type. Since the characteristic of the fractionation apparatus of the invention resides in the nature of the membrane used, the factors involved in these apparatuses are essentially the same as those of known apparatus. In particular, it is possible to use apparatuses which employ semi-permeable membranes in the form of plates, cones, tubes, spirals and strips.
Further details of the features of ultra-filtration apparatuses, can be found in the following documents: French Pat. Nos. 1,252,995, 1,512,555, 1,583,221, 1,429,635 and 2,001,558, U.S. Pat. Nos. 3,341,024 and 3,131,143, Canadian Pat. No. 819,509 and German Pat. No. 2,119,906. Further details of the features of dialysis apparatus, can be found in the following documents: Ind. Eng. Chem. 54 (6) 20-8 (1962), French Pat. Nos. 1,527,944, 1,528,430, 1,397,297, 1,464,722, 1,518,607 and 1,597,874, R. N. RICKLES, "Membranes technology and Economics" (1967 edition), Kirk-Othmer, Encyclopaedia of Chemical Technology 5, 1-20 (1st edition) and 7, 1-21 (2nd edition), U.S. Pat. No. 3,186,917 and German Pat. Nos. 1,245,322 and 1,921,201.
The dialysis apparatus of the present invention can be used as, for example, artificial kidneys which permit purification of the blood and especially the removal of urea, as well as apparatus for the elimination of ascites liquid.
The membranes of this invention can, of course, also be used for dialysis without the aid of particular apparatus; to do this, the solution to be dialysed may be enclosed in a sealed pouch made from the dialysis membrane, and this pouch immersed in a dialysis bath, i.e. a dilute solution of low molecular weight material.
There are numerous practical applications involving ultrafiltration and dialysis with the membranes and apparatuses of this invention. Such applications include the concentration of foodstuff liquids such as milk, whey, buttermilk, fruit juices and meat juices; the concentration of macromolecular products used in the pharmaceutical industry, such as solutions or suspensions of antibiotics, viruses, bacteria, proteins and enzymes; the concentration and/or the purification of latex and of emulsions of natural or synthetic polymers; the separation of aminoacids, steroids, sugars, hormones and alkaloids from mixtures with compounds of higher molecular weight; the purification of blood, plasma or serum; the purification of effluents; and the sterilisation of water.
The following examples further illustrate the present invention:
A series of membranes was produced observing the following general procedure (the particular conditions are indicated in Table I):
A copolymer of acrylonitrile, an ionic monomer and, optionally, a third monomer was dissolved in dimethylformamide (DMF) so as to obtain the specified concentration.
This solution was cast onto a glass plate so as to obtain a liquid film 0.5 mm thick, which was thereafter dried in a ventilated oven at 60° C. for the period indicated; the dried film was detached from its support and treated with hot water; to carry out this treatment, the dry film was immersed in a vessel containing water and the whole was heated to the maximum temperature indicated, and this temperature was maintained for 10 minutes (in the case of the Examples where this temperature exceeds 100° C., the vessel containing the water and the film was closed and kept under .[.orthogenic.]..Iadd.autogenous .Iaddend.pressure); thereafter the heating was stopped and the vessel allowed to cool to ambient temperature whilst leaving the membrane immersed in the water in the vessel.
All the membranes thus prepared showed a zero degree of salt rejection. Their permeability to water was measured as follows:
12 cm2 of membrane were placed on a porous sintered metal plate; water was placed in contact with the free face of the membrane and a pressure of 2 bars applied thereto. The flow of water across the membrane was measured; this flow, expressed in liters/m2.day, is the permeability of the membrane to water.
Specific information relating to certain examples:
The polymer used was a mixture of two copolymers in a weight ratio of 43/57. The first was a copolymer of acrylonitrile and sodium methallylsulphonate in a weight ratio of 82/18; the second was a copolymer of acrylonitrile and styrene in a weight ratio of 85/15.
The polymer used was a mixture of equal weights of two copolymers; one was a copolymer of acrylonitrile and sodium methallylsulphonate in a weight ratio of 82/18, the other was a copolymer of acrylonitrile and butyl acrylate in a weight ratio of 85/15.
The polymer mixture used only differs from that of Example 14 in that the butyl acrylate was replaced by an equal weight of vinyl benzoate.
The membranes prepared in Example 1 to 16 were used firstly in ultrafiltration processes (A) and secondly in dialysis processes (B).
(A) 12 cm2 of membrane were placed on a porous sintered metal plate; an aqueous solution of a specified macromolecular product was placed in contact with the free face of the membrane and a pressure of 2 bars applied thereto; the flow of ultrafiltrate in liters/day.m2, as well as the degree of rejection expressed as a percentage, namely ##EQU2## was measured.
Tables II and III give details of the solution subjected to ultrafiltration, as well as the flow of ultrafiltrate and the degree of rejection of the macromolecule.
(B) A dialysis cell was divided into two compartments by a membrane having 10 cm2 surface area. 100 cm3 of an aqueous solution containing 9 g/l of NaCl, 1 g/l of thiourea and 10 g/l of cattle albumen (molecular weight: approx. 70,000) flowed in closed circuit through the first compartment: this solution, hereafter referred to as "synthetic blood", circulated in the compartment at a flow rate of 1l/hour. 100 cm3 of an aqueous solution containing 10 g of NaCl/l flowed in closed circuit through the second compartment, this solution being hereafter called the "dialysis bath"; it circulated in the compartment at a flow rate of 0.9 l/hour.
The rate of dialysis was measured by determining the time in minutes taken for the concentration of thiourea in the dialysis bath to reach 0.1 g/l; this time is indicated for certain membranes in Table (II).
TABLE I__________________________________________________________________________ ExampleNature of polymer 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16__________________________________________________________________________Molar percentages of comonomers(made up to 100% with acrylonitrile)Sodium methallyl- 2.094 3.32 3.71 5.74 6.35 7.16 2.60 3.33 2.58 -3.36 3.90 3.91sulphonatePotassium vinyloxy- 3.40benzenesulphonateSodium vinylsulphonate 5.08N-methyl-4-vinyl- 4.28 6.21pyridinium sulphateMethyl methacrylate 5.79Butyl acrylate 3.45Vinyl benzoate 2.99Vinylidene chloride 4.51Acrylamide 7.97Styrene 4.75Specific viscosity 0.812 1.039 0.743 0.980 1.026 0.962 1.192 0.62 0.374 0.926 0.63(measured at 25° C., at2 g/l in DMF)Concentration of the 9 8 8.5 10 10 10 10 10 10 10 10 10 8 10 10 7copolymer solution(% by weight)Duration of drying in 42 67 42 45 52 24 24 48 48 40 70 72 72 24 24 21the oven, in hoursMaximum temperature of 180 147 146 113 104 92 146 140 140 146 146 147 145 145 145 120the treatment water,in °C.Thickness of the mem- 45 65 55 50 80 45 60 55 45 60 55 90 80 70 70 30brane, in micronsPermeability to water 230 350 520 650 300 480 800 600 800 570 8000 2900 1800 1500 2600 360under 2 bars pressure,in l/day · m2Tensile strength of the 130 130 100 90membrane in kg/cm2(measured at 23° C.whilst wet)Tensile elongation at 48 31 41 41break, in %__________________________________________________________________________
TABLE II__________________________________________________________________________ Example 17 18 19 20 21 22 23__________________________________________________________________________Membrane used, prepared according to 2 3 3 3 4 5 6ExampleUltrafiltrationNature of the initial solutionsubjected to ultrafiltrationConcentration of NaCl in g/l 9 9 5.85 0 9 9 9Nature of the macromolecule cattle cattle pepsin dextran cattle cattle cattle albumen albumen albumen albumen albumenAverage molecular weight of the 70,000 70,000 36,000 10,000 70,000 70,000 70,000macromoleculeConcentration of macromolecule in g/l 10 10 0.5 4 10 10 10Results obtainedFlow of ultrafiltrate in liters/day · m2 350 520 520 520 720 300 480Degree of rejection in % 100 100 70 50 98 98.5 100DialysisRate of dialysis in minutes 52__________________________________________________________________________ Example 24 25 26 27 28 29 30__________________________________________________________________________Membrane used, prepared according to 6 6 7 8 8 8 9ExampleUltrafiltrationNature of the initial solutionsubjected to ultrafiltrationConcentration of NaCl in g/l 5.85 0 9 9 0 0 9Nature of the macromolecule lysozyme dextran cattle cattle dextran dextran cattle albumen albumen albumenAverage molecular weight of the 15,000 10,000 70,000 70,000 40,000 10,000 70,000macromoleculeConcentration of macromolecule in g/l 0.5 4 10 10 4 4 1Results obtainedFlow of ultrafiltrate in liters/day · m2 480 480 760 600 600 600 700Degree of rejection in % 100 40 100 100 50 28 100DialysisRate of dialysis in minutes 58__________________________________________________________________________
TABLE III__________________________________________________________________________ Example 31 32 33 34 35 36 37__________________________________________________________________________Membrane used, prepared according to Example 10 11 12 13 14 15 16UltrafiltrationNature of the initial solutionsubjected to ultrafiltrationConcentration of NaCl in g/l 9 9 9 9 9 9 9Nature of the macromolecule cattle cattle cattle cattle cattle cattle cattle albumen albumen albumen albumen albumen albumen albumenAverage molecular weight of the 70,000 70,000 70,000 70,000 70,000 70,000 70,000macromoleuleConcentration of macromolecule in g/l 10 10 10 10 10 10 10Results obtainedFlow of ultrafiltrate in liters/day · m2 480 720 1,000 1,000 1,000 1,330 360Degree of rejection in % 99 90 90 96 93 90 100__________________________________________________________________________
Milk was concentrated in an ultrafiltration cell with the two compartments separated by a membrane prepared as in Example 3, having a useful surface area of 465 cm2. A relative pressure (relative to the second compartment) of 3 bars prevailed in the first compartment. The membrane was supported by a rigid plate of sintered polyethylene. Milk was circulated between this compartment and a storage reservoir; the rate of circulation at the membrane was 85 cm/second and the total weight of milk in circulation was initially 8.015 kg.
The whole operation, which was carried out at a temperature of +4° C., was continued for 11 hours 30 minutes. 4.007 kg of ultrafiltrate containing essentially, water, inorganic salts, lactose, and non-protein nitrogen-containing components had been collected in the second compartment; this amount of ultrafiltrate corresponds to a flow rate of 180 kg/day.m2 ; the milk obtained in the first compartment had thus been concentrated two-fold.
Example 38 was repeated with the following modifications: the rate of circulation of the milk in the first compartment was 1 m/second, the temperature was +45° C., and the relative pressure between the two compartments was 6 bars.
After 11 hours 30 minutes, 6.835 kg of ultrafiltrate had been collected, corresponding to a flow rate of 307 kg/day.m2 ; the milk obtained in the first compartment had been concentrated about seven-fold.
The dialysis experiment of Example 18 was repeated, replacing the so-called "synthetic blood" solution by cattle blood to which was added 1 g/l of thiourea as well as 25% by volume (the percentage being expressed relative to the blood) of a solution consisting of: 1.66 g of citric acid, 0.6 g of sodium hydroxide, 3 g of glucose and water sufficient to give 100 cm3 of solution.
The rate of dialysis (expressed in minutes, in accordance with the definition given above) was 91 minutes.
The following were introduced into a glass reactor: 330 g of a copolymer of acrylonitrile and sodium methallylsulphonate in the relative weight ratio of 91/9; the specific viscosity of the copolymer (measured at 25° C. in a 2 g/l solution in DMF) being 1; and 1600 cm3 Of DMF.
The mixture was stirred for 1 hour at 20° C. and then for 4 hours at 90° C. The gases which may have been dissolved were then removed by placing the reactor under a pressure of 100 mm/Hg for 30 minutes; the viscosity of the solution at 23° C. was about 200 poises.
This solution was continuously cast onto a 17 em wide endless stainless steel belt circulating at a speed of 50 cm/minute; a 0.2 mm thick liquid film was thus desposited. The strip then passed into a 1.2 m long ventilated oven heated to 150° C. and was thereafter cooled to 20° C.; the film of acrylonitrile copolymer was moisturised by passing it over a fabric wetted with water and detached from the steel belt on which it was carried; this film then passed for 10 cm, through a bath of water at 90° C.; it issued therefrom at a speed of 140 cm/minute, corresponding to a degree of stretching of 180%. The stretched film then passed through a bath of water at 75° C. over 2 m, without being subjected to any tension whatsover; it issued from this bath at a speed of 100 cm/minute and then passed through a bath of glycerine (a mixture of water and glycerine in a weight ratio of 20/80) over 2 m, after which it was dried by passing between two rollers so as to drive off the excess glycerine.
A 30μ thick membrane was thus obtained; it had a permeability to water, under 2 bars, of 860 liters/day.m2 and can be stored dry. Its degree of rejection was 100% for cattle albumen (molecular weight: 70,000) and for ovalbumin (molecular weight: 45,000); it was only 53% for dextran (molecular weight: 40,000).
Example 41 is repeated, varying the degree of stretching. The following results were obtained:
______________________________________ Example 42 43 44______________________________________Degree of stretching in % 165 135 100Permeability to water under 505 360 2162 bars (l/day · m2)Degree of rejection in %Cattle albumen, 100 100 100molecular weight: 70,000Ovalbumin, 100 100 100molecular weight: 45,000Pepsin, >90% >90% 100molecular weight: 36,000Lysozyme >90% >90% 100molecular weight: 15,000Dextran, 74 78 85molecular weight: 40,000______________________________________
A membrane was prepared as in Example 41, but with a degree of stretching of 185%.
This membrane was used for the ultrafiltration of river-water (the Rhone, downstream from the city of Lyon) containing fecal streptococci and "Escherichia coli" bacteria. The difference in pressure between the first and the second compartment of the ultrafiltration apparatus was 2 bars; in the first compartment the river-water circulated over the surface of the membrane at a speed of 115 cm/second; a permeate of potable water was collected at the rate of 1150 l/day.m2 ; the potable character of this water was determined by bacteriological examinations, which showed the total absence of the bacteria mentioned above.
The membrane of Example 41 was used for the ultrafiltration of 3.5 liters of whey having a solids content of 65 g/l, a lactose concentration of 50 g/l and a protein concentration of 7.6 g/l.
The difference in pressure between the two ultrafiltration compartments was 2.5 bars; the speed of circulation of the whey in the first compartment was 50 cm/second at the surface of the membrane.
The ultrafiltration was continued until 3.250 1 of ultrafiltrate had been obtained; the latter contained 59 g of solids/l, 50 g of lactose/l, and 0.7 g of proteins/l; the concentrate (withdrawn from the first compartment) had a solids content of 168 g/l, a lactose concentration of 48 g/l and a protein concentration of 96 g/l.
Example 46 was repeated, using the membrane of Example 44.
An ultrafiltrate having a solids content of 56 g/l and a lactose concentration of 50 g/l, and containing no proteins, was obtained; the concentrate had a solids content of 155 g/l, a lactose concentration of 58 g/l and a protein concentration of 93 g/l.
Human blood was ultrafiltered at 37° C. in an apparatus of the filter-press type with 8 compartments each possessing a membrane of 125 cm2 surface area, prepared as in Example 41.
The blood circulated in the apparatus in contact with the membranes at a flow rate of 0.2 l/minute; the difference in pressure between the compartments on either side of the membrane was 300 mm/Hg. After running for 8 hours, the protein concentration of the ultrafiltrate was 0.27 g/l; the haematocrit reading of the circulating blood had not varied significantly; the flow rate of ultrafiltrate was 0.4 l/hour.
A membrane was prepared as in Example 41 with the following modifications. The reactor was charged initially with 71 grams of an acrylonitrile/sodium methallylsulphonate copolymer (weight ratio 91/9; having a specific viscosity of 0.979), 179 grams of an acrylonitrile/sodium methallylsulphonate copolymer (in a weight ratio of 89/11; having a specific viscosity of 1.123) and 1200 cm3 of dimethyl formamide.
The drawing ratio was 186%.
A dialysis cell, maintained at 37° C., was separated into two compartments by 625 cm2 of the membrane prepared above. In the first compartment of this cell human blood was circulated, in a closed circuit with a flow of 12.5 cm3 /MM; the total volume of blood in circulation was 1.1 liters and the blood contained 1.5 g/l of urea and 0.15 g/l of .[.creatine.]. .Iadd.creatinine.Iaddend.. In the second compartment was circulated a dialysis bath having the same saline composition as the blood.
A reduction to a half the original concentration in the blood was observed after 1 hour 40 mins for the urea and after 2 hours 25 mins for the .[.creatine.]. .Iadd.creatinine.Iaddend..
An ascitic liquid containing 20 g/l of protein was removed from the peritoneum of a patient suffering from cirrhosis of the liver. This ascitic liquid was introduced to an ultrafiltration apparatus comprising eleven elementary cells arranged in series having a total membrane area of 1450 cm2, prepared as in Example 49 but with a stretching ratio of 182%. The pressure differential across these membranes was 200 mm Hg (the excess pressure being on the side containing the ascitic liquid). The ascitic liquid passed through the membranes where it was concentrated by ultrafiltration and was then reinjected into a vein of the patient. A flow rate of 0.6 l/h was observed for the ultra filtrate while the ascitic liquid which has been concentrated was reinjected into the patient at a flow rate of 0.3 l/h.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3129273 *||Dec 11, 1961||Apr 14, 1964||Dow Chemical Co||Process of producing non-fibrillating acrylonitrile polymer filaments|
|US3247133 *||Nov 2, 1962||Apr 19, 1966||American Mach & Foundry||Method of forming graft copolymer ion exchange membranes|
|US3376168 *||Aug 2, 1962||Apr 2, 1968||Yardney International Corp||Metal-containing graft-polymerized product and method of making same|
|US3532527 *||Nov 4, 1966||Oct 6, 1970||Dow Chemical Co||Permeable separatory membranes|
|US3591493 *||Jun 17, 1968||Jul 6, 1971||Rashid A Zeineh||Method for the treatment of biological fluids and apparatus therefor|
|US3592672 *||Dec 22, 1969||Jul 13, 1971||Eastman Kodak Co||Dry stabilized,rewettable semipermeable cellulose ester and ether membranes and their preparation|
|US3615024 *||Aug 26, 1968||Oct 26, 1971||Amicon Corp||High flow membrane|
|US3616930 *||Mar 18, 1969||Nov 2, 1971||Nat Res Dev||Semipermeable membranes|
|US3647086 *||Jul 9, 1969||Mar 7, 1972||Tokuyama Soda Kk||Cation exchange membrane and method of making same|
|US3648754 *||Jul 28, 1969||Mar 14, 1972||Hugo H Sephton||Vortex flow process and apparatus for enhancing interfacial surface and heat and mass transfer|
|US3723306 *||Feb 19, 1971||Mar 27, 1973||Tee Pak Inc||Separation of ions or molecules from mixtures using graft-polymerized or polymer deposited ion exchange or permselective materials|
|US3750735 *||Jan 19, 1972||Aug 7, 1973||Monsanto Co||Removal of water from liquid mixtures containing formaldehyde using a porous polymeric membrane|
|US3799355 *||Dec 28, 1970||Mar 26, 1974||Us Health Education & Welfare||Dialysis membranes and manufacture|
|US3799356 *||Dec 28, 1970||Mar 26, 1974||Us Health Education & Welfare||Dialysis hollow fiber membranes and manufacture|
|1||*||2nd Annual Contractor s Conference, Jan. 22 24, 1969, Bethesda, Md., pp. 69 & 70.|
|2||2nd Annual Contractor's Conference, Jan. 22-24, 1969, Bethesda, Md., pp. 69 & 70.|
|3||*||Aerojet Jul. 1968 Annual Report PB 179662; p. 24.|
|4||*||Annual Report PB 179662 to National Institute of Arthritis and Metabolic Diseases dated Jul. 1968.|
|5||*||Blood Purif. by Ultrafiltration & Fluid Repl. (Diafiltration); vol. XIII Trans. Amer. Soc. Artif. Int. Organs, 1967 216 226.|
|6||Blood Purif. by Ultrafiltration & Fluid Repl. (Diafiltration); vol. XIII Trans. Amer. Soc. Artif. Int. Organs, 1967 216-226.|
|7||*||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes Annual Report No. 1172 01 3, Jul. 1968.|
|8||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes Annual Report No. 1172-01-3, Jul. 1968.|
|9||*||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes Second Annual Report No. 1172 01 6, Aug. 1969.|
|10||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes Second Annual Report No. 1172-01-6, Aug. 1969.|
|11||*||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes, Third Annual Report No. 1172 01 9, Dec. 1970.|
|12||F. E. Martin, et al. Research and Development of Improved Hemodialysis Membranes, Third Annual Report No. 1172-01-9, Dec. 1970.|
|13||*||Molecular Weight Spectra of Ultrafilter Rejection.I.A Simple HPLC Method Using Homologous Maltodextrin Polymers, Jour. Membrane Science 1983 15 26.|
|14||Molecular Weight Spectra of Ultrafilter Rejection.I.A Simple HPLC Method Using Homologous Maltodextrin Polymers, Jour. Membrane Science 1983 15-26.|
|15||*||Osmose Dialyse Ultrafiltration, Georges Genin 1928; pp. 128 129.|
|16||Osmose Dialyse Ultrafiltration, Georges Genin 1928; pp. 128-129.|
|17||*||Owen B. Laug, et al. The Development of Standard Test Methods for Hemodialysis, NBS Report 9872, NBS Project 1460423, Jul. 30, 1968.|
|18||*||Progress in Separation and Purification, vol. 1, Interscience Publishers; pp. 314 319.|
|19||Progress in Separation and Purification, vol. 1, Interscience Publishers; pp. 314-319.|
|20||*||Second Annual Report PB 192848 to National Institute of Arthritis and Metabolic Diseases, dated Aug. 1969.|
|21||*||The Dev. of a Diafiltration System for Blood Purification, vol. XIV Trans. Amer. Soc. Artif. Int. Organs 1968 pp. 99 108.|
|22||The Dev. of a Diafiltration System for Blood Purification, vol. XIV Trans. Amer. Soc. Artif. Int. Organs 1968 pp. 99-108.|
|23||*||Trans. Amer. Soc. Artif. Int. Organs, vol. XII, 1966 pp. 44 52.|
|24||Trans. Amer. Soc. Artif. Int. Organs, vol. XII, 1966 pp. 44-52.|
|25||*||Ultrafiltration, Lecons De Chime Physique, Hermann & Cie, Editeurs; 1945; p. 78.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7077961||Dec 3, 2001||Jul 18, 2006||Hospal Industrie||Apparatus for extracorporeal blood or plasma treatment comprising a wet semi-permeable membrane and methods for making the same|
|EP0688569A1||Jun 16, 1995||Dec 27, 1995||Hospal Industrie S.A.||Multifunction device for blood treatment|
|EP0710683A1||Oct 16, 1995||May 8, 1996||Hospal Industrie S.A.||Adhesion promoter for polyurethane adhesive compositions|
|U.S. Classification||210/651, 210/500.43|
|International Classification||B01D71/42, A23C9/142|
|Cooperative Classification||B01D71/42, A23C9/1425|
|European Classification||A23C9/142C, B01D71/42|